The Role of Tongxinluo Capsule in Cardiac Disease: Composition, Mechanisms, and Applications
Cardiovascular disease (CVD) has remained the leading cause of death among adults for more than one hundred years. With persistently suboptimal outcomes and a profound economic burden on our healthcare system, there is growing interest in alternative treatment approaches for CVD. One such approach is Tongxinluo (TXL) capsules, a Traditional Chinese Medicine (TCM). TXL is commonly used in China and offers a potentially safe, efficacious, and cost-effective treatment option. To address the limited awareness of TXL in the United States, this narrative review will provide a broad overview of its composition, pharmacological mechanisms, and clinical applications.
Authors
- Menachem Jacobs
- William H. Frishman (ORCID: https://orcid.org/0000-0002-2458-4480)
- Avrohom Karp
- Ben Barris
Institutions
- Westchester Medical Center (US)
- Yale New Haven Hospital (US)
Publication Details
- Journal
- Cardiology in Review
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1097/crd.0000000000000892
- Primary Topic
- Lipid metabolism and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00